Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00517595
Status:
COMPLETED
Last Update Posted:
2012-03-12
First Post:
2007-08-16
Brief Title:
Phase II Study Alimta and Gemzar Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIBIV NSCLC
Sponsor:
Accelerated Community Oncology Research Network
Organization:
Accelerated Community Oncology Research Network
Organization Data
Organization:
Accelerated Community Oncology Research Network
Class:
OTHER
Study ID:
ALJBNSCLC0602
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Accelerated Community Oncology Research Network
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |
| Eli Lilly and Company | INDUSTRY |